Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001193125-23-156944
Filing Date
2023-05-31
Accepted
2023-05-30 21:47:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13E3/A d405754dsc13e3a.htm SC 13E3/A 19932
  Complete submission text file 0001193125-23-156944.txt   21542
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filed by) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-91126 | Film No.: 23978773
SIC: 2834 Pharmaceutical Preparations